Alpha Pro Tech, Ltd. - 10-K Summary (Fiscal Year Ended Dec 31, 2006)
Business Context and Reporting Period
Company: Alpha Pro Tech, Ltd.
Reporting Period: Fiscal year ended December 31, 2006.
Business Overview: The Company develops, manufactures, and markets high-value disposable protective apparel, infection control products, extended care products (medical bed pads, pet beds), and engineered construction products (house wrap, roof underlayment, antimicrobial paint). Operations are conducted through four segments: Disposable Protective Apparel, Infection Control, Extended Care, and Engineered Products.
Key Financial Metrics
| Metric | 2006 | 2005 |
|---|---|---|
| Net Sales | $37,338,000 | $31,095,000 |
| Gross Profit | $17,320,000 | $14,147,000 |
| Gross Margin | 46.4% | 45.5% |
| Net Income | $3,739,000 | $2,450,000 |
| Diluted EPS | $0.15 | $0.10 |
| Cash & Equivalents | $1,837,000 | $1,163,000 |
| Working Capital | $19,618,000 | $14,298,000 |
| Debt | $0 | $0 |
| Current Ratio | 8.32:1 | 6.55:1 |
Material Changes vs. Prior Period
- Revenue Growth: Consolidated sales increased 20.1% to $37.3 million, driven primarily by the Engineered Products segment (+65.1%), Infection Control (+35.2%), and Disposable Protective Apparel (+8.9%).
- Profitability: Net income rose 52.6% to $3.7 million. Gross margin improved to 46.4% due to better margins in the Engineered Products segment.
- Segment Performance:
- Engineered Products: Sales grew to $7.8 million, aided by Miami-Dade and ICC-ES approvals for synthetic roof underlayment.
- Infection Control: Sales increased to $6.9 million, largely due to N-95 respirator demand related to Avian Flu concerns.
- Extended Care: Sales declined 20.6% to $1.4 million due to lower medical bed pad sales.
- Liquidity: Cash increased by $674,000, supported by stock option exercises ($734,000) and repayment of a joint venture advance ($500,000), offset by cash used in operations ($427,000) due to inventory and receivable build-up.
Guidance, Outlook, and Risks
- Outlook: Management expects significant growth in 2007 from the Engineered Products segment and the new "ComforTech" line in the Disposable Protective Apparel segment. The Company plans to introduce "ComforTech Sterile" products in 2007.
- Capital Expenditures: Anticipated equipment purchases of $1.0 million to $1.5 million in 2007, primarily for the Engineered Products segment.
- Key Risks:
- Customer Concentration: Sales to the largest distributor (VWR International) represented 45.1% of total sales in 2006. The loss of this customer would have a material adverse effect.
- Supplier Concentration: Significant reliance on a single third-party subcontractor in China for disposable apparel and a joint venture in India for engineered products.
- Market Volatility: Infection Control sales are sensitive to global health concerns (e.g., Avian Flu); sales could soften if concerns subside.
- Unusual Items: The Company adopted SFAS 123R in 2006, recognizing $51,000 in share-based compensation expense. No dividends are paid; earnings are retained for growth.
Investor Verification Checklist
- Verify the sustainability of the 45.1% revenue concentration with VWR International and the status of the new non-exclusive distribution rights.
- Assess the durability of the Infection Control sales spike driven by Avian Flu fears versus long-term demand.
- Monitor the repayment schedule and performance of the Harmony Plastics joint venture in India (41.66% ownership).
- Review the inventory build-up ($2.1 million increase) to ensure it aligns with sales growth and does not indicate obsolescence risks.
- Confirm the timeline for the rollout of new "ComforTech" and "REX" branded products to validate 2007 growth projections.